Our mission is to enable UW researchers and clinicians as well as external partners to develop advanced cell & gene therapies through FDA CBER IND-enabling and Phase I/II clinical studies. We provide place-of-care vein-to-vein (POCV2V) cell therapy manufacture, regulatory and capitalizing our UW Health clinical center of excellence for clinical deployment capabilities. Our vision is to enable BLA line of sight development and deployment of POCV2V cell technologies.
We assist in the development of Standard Operating Procedures and Batch Production Records in support of new FDA CBER INDs. Our team optimizes the manufacturing processes, including FDA-compliant production of variety of cell types, advanced cell manufacturing and cell enrichment. We offer services to assist researchers and clinicians in various aspects of IND filing including writing/reviewing of CMC and supporting reports.
We are engaged in several Phase I clinical trials and are open to multi center trials for academic and clinical-stage companies in cell technology space. We partner with biotechnology and medical device companies to integrate their semi-automated and fully automated devices to improve GMP workflow. We welcome academic and industry partners to work with us to design new technologies/devices or improve existing technologies/devices that can be used in the GMP cell manufacturing laboratories.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 1111 Highland Ave,, Madison,wi 53705,united States
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://www.pact.wisc.edu
- Keywords
- cell therapy, regenerative medicine, virus-specific T-cells, mesenchymal stromal cells, GMP cell manufacturing, Phase I clinical trials, tissue engineering, FDA CBER regulatory expertise, cancer, immune deficiency, xerostomia, CAR-T, Miltenyi prodigy.
- HQ
- Madison, WI
- Competitors
- Australian Wagyu Association, BioCell Innovations Pte Ltd, YSF-ESB, ISCT, International Society for Cell & Gene Therapy, Fletcher Biosciences, UW Carbone Cancer Center, Curocell, Foundation for the Accreditation of Cellular Therapy, 財團法人醫藥品查驗中心 (Center for Drug Evaluation, CDE), TJ Biopharma.
Uw Program For Advanced Cell Therapy Questions
Uw Program For Advanced Cell Therapy's website is http://www.pact.wisc.edu
Uw Program For Advanced Cell Therapy's LinkedIn profile is https://www.linkedin.com/company/uw-madison-program-for-advanced-cell-therapy
Uw Program For Advanced Cell Therapy has
9 employees.
View email and phone details for 9
employees at Uw Program For Advanced Cell Therapy.
Uw Program For Advanced Cell Therapy's industry is
Hospitals and Health Care
Uw Program For Advanced Cell Therapy's top competitors are
Australian Wagyu Association,
Biocell Innovations Pte Ltd,
Ysf-Esb,
Isct, International Society For Cell & Gene Therapy,
Fletcher Biosciences,
Uw Carbone Cancer Center,
Curocell,
Foundation For The Accreditation Of Cellular Therapy,
財團法人醫藥品查驗中心 (Center For Drug Evaluation, Cde),
Tj Biopharma.
Uw Program For Advanced Cell Therapy's categories are Hospitals and Health Care
Uw Program For Advanced Cell Therapy's founding year is 2017
